Several recent investigations have shown that early therapeutic administration of IL-10 is effective in preventing the initial surge in TNF-α observed after traumatic hemorrhagic shock[33], and also in reducing the systemic inflammatory response and lethality in murine models of sepsis and reperfusion injury[34]. The gene discussed is TNF; the disease is Sepsis.